"The Patent Cliff Ahead: 5 Key Takeaways for Pharma Executives to Navigate the Coming Wave of Expired Medications
As the pharmaceutical industry continues to evolve, one constant remains: the expiration of patents for blockbuster medications. With…
Patent Expiration Calendar: Strategic Planning Guide for Pharma Executives Read Post »
"The Patent Puzzle: As AI Takes Center Stage in Drug Discovery, Who Will Own the Breakthroughs?
The intersection of artificial intelligence and pharmaceutical innovation has yielded unprecedented results, but a pressing question remains: who will …
AI Meets Drug Discovery – But Who Gets the Patent? Read Post »
"Breaking Down Barriers: How MRAs Can Supercharge Generic Drug Approvals
In a move that could revolutionize the generic drug industry, Mutual Recognition Agreements (MRAs) are being leveraged to fast-track approvals, cutting years off the time it …
Leveraging Mutual Recognition Agreements MRA to Fast-Track Generic Drug Approvals Read Post »
"The Unseen Pillar of Healthcare: How Specialty Generics Are Revolutionizing the Pharmaceutical Landscape
As the pharmaceutical industry grapples with rising costs and accessibility issues, a quiet revolution is underway. Specialty generics, once …
The Growing Importance of Specialty Generics in the Pharmaceutical Market Read Post »
"The Future of Medicine is at Stake: How Patent Protection Can Make or Break Precision Medicine Innovations
As the healthcare landscape continues to evolve at breakneck speed, precision medicine is poised to revolutionize the way we treat disease….
"Breaking Down Barriers: How Generic Drug Makers Are Revolutionizing the Industry with Precision and Reproducibility
As the pharmaceutical industry continues to grapple with rising costs and limited access to life-saving medications, a quiet revol…
Precision and Reproducibility in Generic Drug Reverse Engineering Read Post »
"The Future of Pharma is Written in Code: Can AI-Designed Drugs Be Owned?
As the pharmaceutical industry grapples with the rise of generative AI, a new question is emerging: can machines truly own the intellectual property rights to the medicines …
Generative AI Can Design Drugs. But Can It Own Them? Read Post »
"The Patent Linkage System: A Game-Changer for Canadian Healthcare?
As Canada prepares to implement the Patent Linkage System, a long-awaited reform aimed at promoting generic competition and reducing prescription costs, the stakes are higher than…
"The Dragon’s Rise: How China’s Pharmaceutical Industry is Igniting a Global Revolution
As the world’s second-largest economy continues to surge, a quiet revolution is unfolding in the pharmaceutical sector. China’s pharmaceutical industry, once a…
"The Silent Shift in Pharmacy Benefits: How PBMs are Redefining Their Role – and Raising Questions About Transparency and Patient Care
As the pharmacy benefits management (PBM) industry continues to evolve, a seismic shift is underway. Gone are th…
Get new actionable insights and updates from BiotechBlog
